Facebook
Twitter
Telegram
Report an ErrorVYNE Therapeutics Income Statement 2011-2024 | VYNE
Annual Income Statement VYNE Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
21.9 M | 7.77 M | 2.92 M | 257 M | - | - | - | - | - | - | - | - | - |
Shares |
10.3 M | 3.19 M | 2.86 M | 32.4 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
2.13 | 2.44 | 1.02 | 6.32 | 18.6 | 16.5 | - | - | - | - | - | - | - |
Net Income |
-28.5 M | -23.2 M | -73.3 M | -256 M | -73.7 M | -51.4 M | -29.1 M | -14.1 M | -4.61 M | - | - | - | - |
Revenue |
424 K | 477 K | 931 K | 21 M | - | 10.6 M | 4.58 M | 674 K | - | - | - | - | - |
Cost of Revenue |
- | - | - | 1.39 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 19.6 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-29.3 M | -34.3 M | -38.9 M | -253 M | -95.9 M | -74.9 M | -29.6 M | -14.3 M | -4.61 M | - | - | - | - |
Interest Expense |
1.39 M | 363 K | 5.61 M | 4.39 M | 921 K | - | 517 K | 264 K | - | - | - | - | - |
EBITDA |
- | -34.2 M | -38.8 M | -113 M | -75.5 M | -54.5 M | -29.6 M | -14.3 M | -4.61 M | - | - | - | - |
Operating Expenses |
- | - | - | 133 M | 76.2 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
13.4 M | 16.4 M | 20.3 M | 89.5 M | 22.5 M | 12.2 M | 5.17 M | 3.75 M | 1.69 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement VYNE Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
3.28 M | 3.27 M | 3.26 M | 3.23 M | 3.22 M | 3.22 M | 3.08 M | 53.6 M | 52 M | 51.4 M | 48.9 M | 43.2 M | 41.9 M | 34.7 M | 10.6 M | 9.12 M | 101 M | 98 M | 32.2 M | 23.2 M | 23 M | 22.9 M | 17.6 M | 5.3 M | 5.12 M | 5.09 M | 5.07 M | 5.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-6.58 M | -10.1 M | -5.62 M | - | -9.46 M | -8.48 M | 4.67 M | - | -21.3 M | -19.9 M | -20.6 M | - | -24.7 M | -167 M | -40.2 M | -21.5 M | -23.2 M | -19 M | -15.2 M | -17.6 M | -12.8 M | -8.35 M | -12.7 M | -9.28 M | -8.17 M | -6.15 M | -5.47 M | -4.84 M | -3.4 M | -3.56 M | -2.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
114 K | 135 K | 99 K | - | 167 K | 126 K | 178 K | - | 133 K | 295 K | 230 K | 4.29 M | 3.27 M | 11.7 M | 1.75 M | 135 K | - | - | 308 K | - | 10.6 M | 10.1 M | 497 K | 2.78 M | 909 K | 449 K | 449 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | 1.05 M | 795 K | 601 K | 24.9 M | 26.8 M | 179 M | 41.6 M | - | 23.2 M | 19.4 M | 16.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-6.23 M | -10.3 M | -5.88 M | - | -9.33 M | -8.29 M | -8.69 M | - | -10.8 M | -9.54 M | -9.76 M | -22 M | -23.5 M | -167 M | -39.9 M | -37.4 M | -23.2 M | -19.4 M | -15.9 M | - | -13.7 M | -9.17 M | -13.2 M | - | -8.34 M | -6.22 M | -5.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
163 K | 280 K | 263 K | - | 78 K | 52 K | -3 K | - | 3.47 M | 1.07 M | 1.06 M | - | 1.09 M | 1.07 M | 1.07 M | - | 571 K | 739 K | 796 K | - | 855 K | 826 K | 563 K | - | 163 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | -9.11 M | -8.23 M | -8.65 M | - | -10.7 M | -9.49 M | -9.73 M | -22 M | -23.2 M | -167 M | -39.8 M | -37.4 M | -22.9 M | -19.2 M | -15.8 M | - | -13.7 M | -9.17 M | -13.2 M | - | -8.34 M | -6.22 M | -5.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.9 M | 17.4 M | 17.2 M | 19.7 M | 18.4 M | 13.7 M | 19.3 M | 13.7 M | 12.3 M | 9.24 M | 6.67 M | 6 M | 5.37 M | 3.7 M | 3.64 M | 2.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.03 M | 3.22 M | 3.24 M | - | 3.95 M | 4.3 M | 4.42 M | - | 4.98 M | 4.79 M | 5.73 M | - | 19.8 M | 26.5 M | 25.4 M | - | 4.8 M | 3.76 M | 3.75 M | - | 3.04 M | 3.09 M | 2.7 M | - | 1.24 M | 1.21 M | 1.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency